Montag, 23. März 2009

In Re Northwest Biotherapeutics, Inc. Securities Litigation

Trading Symbol: N/A
CUSIP Number: N/A

TERMS OF THE SETTLEMENT: The Settlement consists of $1,000,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the publicly-traded common stock of Northwest Biotherapeutics, Inc. traded on the U.S. and/or London markets during the period from April 17, 2007 through July 18, 2007, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 16, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 16, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

In Re ACE Limited Securities Litigation

Trading Symbol: N/A
CUSIP Number: N/A

TERMS OF THE SETTLEMENT: The Settlement consists of $1,950,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of ACE Limited during then period from October 28, 2003 through October 13, 2004, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: APRIL 30, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JUNE 16, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

In Re Candela Corporation Securities Litigation

Trading Symbol: CLZR
CUSIP Number: 136907102

TERMS OF THE SETTLEMENT: The Settlement consists of $3,850,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of Candela Corporation during the period from November 1, 2005 through August 21, 2006, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: JUNE 9, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JUNE 12, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

Samstag, 14. März 2009

In Re Bradley Pharmaceuticals, Inc. Securities Litigation

Trading Symbol: N/A
CUSIP Number: N/A

TERMS OF THE SETTLEMENT: The Settlement consists of $3,500,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of Bradley Pharmaceuticals, Inc. during the period from October 28, 2004 through February 25, 2005, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 20, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 20, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

In Re Coast Financial Holdings, Inc. Securities Litigation

Trading Symbol: N/A
CUSIP Number: N/A

TERMS OF THE SETTLEMENT: The Settlement consists of $6,349,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of Coast Financial Holdings, Inc. during the period from January 21, 2005 through January 22, 2007, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 8, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 6, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

In Re Leadis Technology, Inc. Securities Litigation

Trading Symbol: LDIS
CUSIP Number: 52171N103

TERMS OF THE SETTLEMENT: The Settlement consists of $4,200,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of Leadis Technology, Inc. pursuant to or traceable to the Company’s Initial Public Offering or any shares purchased on the open market between June 16, 2004 through March 2, 2005, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 29, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 10, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

In Re Sourcefire, Inc. Securities Litigation

Trading Symbol: FIRE
CUSIP Number: 83616T108

TERMS OF THE SETTLEMENT: The Settlement consists of $3,200,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the publicly traded common stock of Sourcefire, Inc. during the period from March 9, 2007 through April 5, 2007, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: APRIL 23, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JUNE 8, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

In Re Sonus Networks, Inc. Securities Litigation

Trading Symbol: SONS
CUSIP Number: 835916107

TERMS OF THE SETTLEMENT: The Settlement consists of $9,500,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of Sonus Networks, Inc. during the period from December 11, 2000 through January 16, 2002, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 15, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 5, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com